The integration of AI in the stock market has opened up new opportunities for traders and investors to make well-informed decisions. Specifically, in the case of Organon & Co (OGN), Tickeron's Swing Trader for Beginners: Search for Trend Reversals (TA&FA) bot has been a top performer in their robot factory. Traders can access this bot through the Tickeron website and gain valuable insights into potential trading opportunities. By utilizing AI and technical analysis, the bot provides recommendations for buying and selling AI stock.
Organon & Co (OGN) has seen a rough start to the year, with the stock falling -25.36% over the last three months to $23.59 per share. However, the latest analysis from A.I.dvisor reveals that OGN could be ready for a rebound.
A.I.dvisor analyzed 57 stocks in the Pharmaceuticals: Major Industry for the 3-month period ending April 18, 2023, and found that 58.82% exhibited an Uptrend while 41.18% demonstrated a Downtrend. Despite OGN's recent decline, traders should take note of the Momentum Indicator turning positive on March 28, 2023. This shift indicates that the stock could be entering a new upward trend.
If the Momentum Indicator's past performance is any indication, traders may want to consider buying OGN stock or call options. Tickeron's A.I.dvisor analyzed 28 similar instances where the indicator turned positive, and in 21 of those cases, the stock moved higher in the following days. The odds of a move higher this time are at an impressive 75%.
Despite the recent dip, the positive Momentum Indicator coupled with the favorable odds for a move higher could make Organon & Co an attractive investment opportunity for traders. As always, it's important to conduct thorough research and analysis before making any investment decisions.
Our platform utilizes the power of AI to provide you with valuable insights and analysis, helping you make informed decisions when it comes to trading and investing. Don't miss out on this opportunity to take your stock market game to the next level. Register with us now and start making money! If you're interested in stocks and want to stay ahead of the game, consider registering with us, click here.
OGN moved below its 50-day moving average on May 04, 2023 date and that indicates a change from an upward trend to a downward trend. In of 11 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Momentum Indicator moved below the 0 level on May 04, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on OGN as a result. In of 29 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 10-day moving average for OGN crossed bearishly below the 50-day moving average on May 10, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 6 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for OGN entered a downward trend on June 09, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where OGN's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for OGN just turned positive on June 05, 2023. Looking at past instances where OGN's MACD turned positive, the stock continued to rise in of 12 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OGN advanced for three days, in of 112 cases, the price rose further within the following month. The odds of a continued upward trend are .
OGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (6.381). P/E Ratio (6.854) is within average values for comparable stocks, (31.179). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.425). OGN's Dividend Yield (0.056) is considerably higher than the industry average of (0.027). P/S Ratio (0.832) is also within normal values, averaging (4.122).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PharmaceuticalsMajor
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NRGD | 334.15 | 2.95 | +0.89% |
MicroSectors™ US Big Oil -3X Ivs Lgd ETN | |||
BUFD | 21.14 | 0.03 | +0.14% |
FT Cboe Vest Fund of Deep Buffer ETFs | |||
APRT | 30.65 | 0.03 | +0.09% |
AllianzIM US Large Cap Buffer10 Apr ETF | |||
HVAL | 23.64 | N/A | N/A |
ALPS Hillman Active Value ETF | |||
SRLN | 41.30 | N/A | N/A |
SPDR Blackstone Senior Loan ETF |
A.I.dvisor indicates that over the last year, OGN has been loosely correlated with AZN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then AZN could also see price increases.